Biovail files d-methylphenidate NDS

Biovail (BVF; TSE:BVF) filed an NDS in Canada for its chirally pure d-methylphenidate to treat attention deficit disorder (ADD) and attention deficit and hyperacticity disorder (ADHD). The filing trig...